Congress Needs to F...
Health Care: Health Services
Vasomedical Incorporated (VASO: OTC)
$0.23 -0.01 | -5.38%
02/09/12 - 03:07 PM ET
7.70K / 118.30K
Vol / Avg. Vol:0.23 / 0.24
Open / Prev. Close:0.23 - 0.24
Today's Range:0.18 - 0.75
52 Wk Range:21.28%
Performance YTD:TheStreet Rating:
Portfolios with VASO
- Portfolio NameUser Type
Latest VASO Headlines from TheStreet
- Vasomedical Releases IPhone Application For EECP(R) Therapy 07.20.10 | 01:07 pm
- Vasomedical Announces Reorganization Of Its Board Of Directors 06.29.10 | 04:06 pm
- Death Spiral Convertible Just Refuses to Die 05.11.06 | 07:05 am
- Health Stocks in Motion 01.14.05 | 04:01 pm
- The Night Watch: Chattem Lower on Secondary 06.17.02 | 05:06 pm
Press Releases for VASO
- Vasomedical Recorded Record Net Income Of $2.47 Million For The Second Quarter Of Fiscal 2012 - Business Wire 01.17.12 | 08:01 am
- Studies Show Beneficial Effect Of Enhanced External Counterpulsation (EECP) Therapy In Diabetic Patients - Business Wire 01.05.12 | 09:01 am
- Vasomedical Reports Financial Results For The Quarter Ended August 31, 2011 - Business Wire 10.17.11 | 04:10 pm
- Vasomedical Announces Corporate Restructure And Appointment Of New Chief Financial Officer - Business Wire 09.21.11 | 09:09 am
- Vasomedical Completes Acquisition Of Life Enhancement Technology And Biox Instruments - Business Wire 09.08.11 | 09:09 am
- Vasomedical Reports Financial Results For The Year Ended May, 31, 2011 - Business Wire 08.30.11 | 09:08 am
- Vasomedical Announces Agreement To Acquire Two China-based Companies - Business Wire 08.23.11 | 09:08 am
- Vasomedical Receives FDA 510(k) Clearance On Two Additional BIOX™ Monitors - Business Wire 07.06.11 | 09:07 am
- Vasomedical Receives FDA 510(k) Clearance On Two New Devices - Business Wire 06.29.11 | 04:06 pm
- Vasomedical Reports Financial Results For The Quarter Ended February, 28, 2011 - Business Wire 04.15.11 | 09:04 am
Partner Headlines for VASO
